A real-world feasibility study: at home longitudinal use of the Cumulus NeuLogiq® platform for electrophysiological and neurocognitive measures in patients with mild Alzheimer's Disease dementia

IntroductionDementias, including those caused by Alzheimer's Disease (AD), are a leading global cause of death, necessitating improvements in early detection and development of more effective disease-modifying therapies. Well-validated pen-and-paper measures serve as the primary method used for cogn...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Shannon Diggin, Laura Rueda-Delgado, Alison Buick, John F. Dyer, Azar Alexander-Sefre, Florentine Barbey, James B. Rowe, Kinan Muhammed, Brian T. Harel, Bryan J. Hansen, Elizabeth Tunbridge, Robert Lai, David J. Hawellek, Ann Marie Hake, Hugh Marston, Ashwini Oswal, Elizabeth Coulthard, Vivek Pattan, Victoria Evans, Stuart Gibson, Christopher Kipps, Rouba Kozak, Nick Mannering, Mark Moss, Viet Nguyen, Kenneth Ruddock, Leslie A. Shinobu, Sofia Toniolo, Brian Murphy
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2026-06-01
coleção:	Frontiers in Digital Health
Assuntos:	Alzheimer's disease at home monitoring digital biomarkers feasibility usability
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fdgth.2026.1840966/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!